These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2599075)

  • 1. [Mechanisms of the antiaggregation activity of 1,4-naphthoquinone derivatives].
    Levin GS; Kalmykova IB; Shneĭvaĭs VB; Kamenetskaia TsL; Dregeris IaIa
    Farmakol Toksikol; 1989; 52(5):37-41. PubMed ID: 2599075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of compounds with antioxidant properties on thrombocyte functional activity].
    Spasov AA; Ostrovskiĭ OV; Ivakhnenko IV; Kosolapov VA; Anisimova VA
    Eksp Klin Farmakol; 1999; 62(1):38-40. PubMed ID: 10198764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The mechanisms of the antioxidant action of shielded phenols in biological membranes. The effects of 4-methyl-2,6-di-tert-butylphenol (ionol) and its derivatives].
    Serbinova E; Kharfuf M; Ukhin LIu; Komissarov VP; Erin AN; Rakovski S; Savov V; Kagan VE
    Biull Eksp Biol Med; 1990 Nov; 110(11):486-9. PubMed ID: 2083329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 2,3-disubstituted 1,4-naphthoquinones as antiplatelet agents.
    Lien JC; Wu CR; Hour MJ; Huang LJ; Huang TF; Kuo SC
    Arch Pharm (Weinheim); 2008 Oct; 341(10):639-44. PubMed ID: 18720342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The antiaggregant activity of the synthetic antioxidant emoxipin].
    Stoliarov VA; Repin AN; Markov VA
    Eksp Klin Farmakol; 1993; 56(2):35-6. PubMed ID: 8348036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet and antithrombotic activities of CP201, a newly synthesized 1,4-naphthoquinone derivative.
    Jin YR; Hwang KA; Cho MR; Kim SY; Kim JH; Ryu CK; Son DJ; Park YH; Yun YP
    Vascul Pharmacol; 2004 Feb; 41(1):35-41. PubMed ID: 15135330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The antiradical activity of coumarin reductones].
    Vladimirov IuA; Parfenov EA; Epanchintseva OM; Smirnov LD
    Biull Eksp Biol Med; 1991 Nov; 112(11):472-5. PubMed ID: 1810479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanisms of the inhibition of Fe2+-induced oxidation of phosphatidylcholine by polyhydroxynaphthoquinones].
    Lebedev AV; Boguslavskaia LV; Levitskiĭ DO; Maksimov OB
    Biokhimiia; 1988 Apr; 53(4):598-603. PubMed ID: 3395641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug derivatives of xanthine].
    Krylov IuF; Karamysheva EI
    Farmakol Toksikol; 1991; 54(5):72-7. PubMed ID: 1800159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antioxidant activity of natural and synthetic quinones].
    Storozhok NM; Drulle AIa; Login IaIa; Dregeris IaIa; Khrapova NG; Burlakova EB
    Vopr Med Khim; 1995; 41(1):16-21. PubMed ID: 7771081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunomodulating effects of vitamin K preparations and its potentiation by riboxine in acute cold stress].
    Bystrova NA; Brovkina IL; Prokopenko LG; Uteshev BS
    Eksp Klin Farmakol; 2000; 63(5):50-3. PubMed ID: 11109528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of nitrogen-containing derivatives of 1,4-naphthoquinone on mitochondrial lipid peroxidation].
    Shneĭvaĭs VB; Drulle AIa; Dregeris IaIa; Levin GS
    Vopr Med Khim; 1992; 38(6):49-52. PubMed ID: 1298133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The action of the alkanol ammonium salts of aroxyacetic acids on the thrombocyte aggregation process].
    Kazimirovskaia VB; Semenova NV; Moskvitina LT; Nepsha VD; Novikova NV; Voronkov MG
    Eksp Klin Farmakol; 1995; 58(3):37-40. PubMed ID: 7663294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of raw versus boiled aqueous extract of garlic and onion on platelet aggregation.
    Ali M; Bordia T; Mustafa T
    Prostaglandins Leukot Essent Fatty Acids; 1999 Jan; 60(1):43-7. PubMed ID: 10319916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiaggregant properties of new 1,3,4-thiadiazine derivatives].
    Vasil'eva TM; Makarov VA; Chupakhin ON; Sidorova LP; Perov NM; Rusinov VL
    Eksp Klin Farmakol; 2009; 72(5):27-30. PubMed ID: 19928572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methodological approaches to restoring the antiaggregation properties of the vascular wall].
    Baluda VP; Baluda MV; Deianov DV; Lukoianova TI; Makarov VA
    Patol Fiziol Eksp Ter; 1987; (4):51-4. PubMed ID: 3684337
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of anti-PDE3 activity of 2-morpholinochromone derivatives reveals multiple mechanisms of anti-platelet activity.
    Abbott BM; Thompson PE
    Bioorg Med Chem Lett; 2006 Feb; 16(4):969-73. PubMed ID: 16290931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 2-alkoxy 1,4-naphthoquinone derivatives as antiplatelet, antiinflammatory, and antiallergic agents.
    Lien JC; Huang LJ; Teng CM; Wang JP; Kuo SC
    Chem Pharm Bull (Tokyo); 2002 May; 50(5):672-4. PubMed ID: 12036028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant activity of a naphthoquinone analog of vitamin K and an inhibitor of coenzyme Q10- enzyme systems.
    Combs AB; Porter TH; Folkers K
    Res Commun Chem Pathol Pharmacol; 1976 Jan; 13(1):109-14. PubMed ID: 1257593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelets activity of some xanthone derivatives.
    Rajtar G; Zółkowska D; Kleinrok Z; Marona H
    Acta Pol Pharm; 1999; 56(4):319-24. PubMed ID: 10635366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.